Identification of potential therapeutic dual inhibitors of EGFR/HER2 in breast cancer

Breast cancer (BC) is the leading cause of death among women worldwide. According to the Breast Cancer Research Foundation (BCRF), 25% of all cases of BC are positive for human epidermal growth factor receptor 2 (HER2), which is the most aggressive phenotype among the five BC subtypes. Previous stud...

Full description

Saved in:
Bibliographic Details
Main Authors: Megha Jethwa (Author), Aditi Gangopadhyay (Author), Achintya Saha (Author)
Format: Book
Published: Elsevier, 2024-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available